Autek China Inc. (SHE:300595)

Market Cap	12.71B -17.6%
Revenue (ttm)	1.82B -1.8%
Net Income	491.70M -24.5%
EPS	0.55 -24.4%
Shares Out	895.29M
PE Ratio	25.79
Forward PE	21.62
Dividend	0.22 (1.57%)
Ex-Dividend Date	Nov 5, 2025

Volume	3,686,251
Average Volume	10,162,281
Open	15.12
Previous Close	14.20
Day's Range	14.02 - 15.12
52-Week Range	13.60 - 19.98
Beta	0.79
RSI	33.61
Earnings Date	Mar 28, 2026

About Autek China

Autek China Inc. engages in the research and development, production, and sale of hard contact lens products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. In addition, the company offers ophthalmic optometry technology services. Autek China Inc. was incorporated in 2000 and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 3,580
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300595

Financial Performance

In 2024, Autek China's revenue was 1.81 billion, an increase of 4.40% compared to the previous year's 1.74 billion. Earnings were 572.23 million, a decrease of -14.16%.